Pooja Khatri, MD, is a professor of neurology and director of the Vascular Neurology Division within the Department of Neurology and Rehabilitation Medicine at the University of Cincinnati (UC) College of Medicine. She also serves as co-director of the Stroke Center of Excellence at the UC Gardner Neuroscience Institute.
Dr. Khatri received her Bachelor of Science with honors in biological sciences from Stanford University and her medical degree with honors from the University of Illinois College of Medicine. After neurology training at the University of Pennsylvania, Dr. Khatri completed her vascular neurology fellowship at UC through the National Institutes of Health (NIH) Specialized Program of Translational Research in Acute Stroke. She also completed a master’s degree in clinical epidemiology from the Harvard University School of Public Health.
A dedicated and highly experienced clinician, Dr. Khatri has almost 20 years of experience providing neurological care to patients at UC Medical Center and emergency stroke care to patients at hospitals throughout the tristate area. She is a recognized expert in clinical stroke, development of novel stroke therapies, stroke epidemiology, and clinical trial design and implementation.
Dr. Khatri’s research spans acute, prevention and recovery fields of stroke, and she co-directs the National Coordinating Center of NIH StrokeNet, a clinical research network of 27 regional coordinating centers and about 500 hospitals in the United States.
NIH StrokeNet is designed to serve as the infrastructure and pipeline for exciting new potential treatment for patients with stroke and those and risk for stroke. The network currently implements over fifteen NIH-funded multicenter trials throughout the United States, and in collaboration with Canada, Germany, United Kingdom, Spain, and Japan.
She has led several NIH and industry-funded international multicenter clinical studies in establishing and optimizing the clinical benefit of reperfusion therapies for acute ischemic stroke; defining acute treatment strategies for mild stroke; optimizing imaging parameters used on stroke clinical trials; and characterizing stroke on a national and population-based level. She currently leads two NIH-funded studies characterizing population-based radiological brain health and its role in predicting stroke recurrence and dementia; an NIH-funded study validating the most promising early biomarkers of motor recovery after stroke; and an investigator-initiated, industry-funded international trial of endovascular therapy for mild stroke. She also directs NIH StrokeNet’s involvement in the NIH-funded ACTIV platform trial of antithrombotic treatments for patients with COVID.
Dr. Khatri has served as a member of FDA advisory panels, the UC local institutional review board (IRB) and data safety and monitoring boards of several phase I, II and III clinical trials. She has authored more than 200 manuscripts in peer-reviewed journals, including national and international clinical guidelines, and is associate editor of the American Heart Association Stroke Journal. Dr. Khatri also serves as secretary on the executive committee of the World Stroke Organization.
Dr. Khatri was a recipient of the NIH Career Development Award and the American Health Association Robert G. Siekert Young Investigator Award. She was also awarded the Cincinnati Business Courier’s Forty Under 40 Award. She is frequently recognized as a “Top Doctor in Cincinnati” by Cincinnati Magazine.